Agenda – jizan hematology

SCHEDULE DETAILS Information of Event Schedules

Day 1
27 Jan 2023
Day 2
28 JAN 2023

Session 1

Moderator:

Dr Ibraheem Motabi

09:00 -09:30

Business models of cancer care

Dr Hammad Alomar

09:30-10:00

Current status and future prospective of cancer care in SA

Dr Abdullah AlSharm

10:00-10:15

Q&A

Session 2

Moderator:

Dr Gad Allah Mohamed

10:15-10:40

Hematology Debate Upfront Brentuximab vedotin in advanced stage HD - Yes

Dr. Saleem Eldadah

10:40-11:10

Hematology Debate Upfront Brentuximab vedotin in advanced stage HD - No

Dr Ibraheem Motabi

11:10-11:20

Discussion

11:20-11:50

South region real life experience with adakveo

Dr Hafiz Melhan

11:50-13:00

Prayer and Lunch

Session 3

Moderator:

Dr Anas Hakeem

13:00-13:25

Optimizing the use of hu in SCA

Dr Gad Allah Mohamed

13:25-13:50

Newer therapeutic modalities for SCD

Dr Ayel Yehya

13:50-14:20

Long-Term Efficacy and Safety of L-Glutamine in Preventing Sickle Cell Disease-Related Acute Complications and Hemolysis in Pediatric and Adult Patients

14:20-14:35

Q&A

Session 4

Moderator:

Dr Ibraheem Motabi

14:50-15:15

ET & PV: diagnosis and management

Dr. Othman Ayoub

15:15-15:40

ASH guidelines for VTE management

Dr. Sarah ALAmmari

15:40-16:05

TTP diagnosis and management

Dr Marwan Shahin

16:05-16:15

Q&A

16:15-16:30

Closing

Session 1

Moderator:

Dr Hafiz Melhan

09:00 -9:30

Treatment overview of Hemophilia A

Dr.Ziyad Alshaibani

09:30-10:00

Treating AML in unfit or elderly patients

Dr. Feras Alfereah

10:00-10:30

Targeted therapy in CLL patients

Dr Anas Hakeem

10:30-10:40

Q&A

Moderator

Dr Gad Allah Mohamed

10:40-11:05

Interpretation of Hb electrophoresis

Dr Ayman Maashi

11:05-11:30

Beta Thalasemia treatment approach

Dr Fahad Bahkali

11:30-12:00

B-thalassemia: Current and Future Advances

sponsored by BMS
Chairman: Dr. Hafiz Malhan

Dr. Abduallah Alzayed

12:00-12:10

Q&A

12:10-13:15

Prayer & Lunch

13:15-13:30

Metabolic Disorders In Hematology Clinics Speaker

Dr Hafiz Melhan

13:30-14:00

Real-life experience with Luspatercept in transfusion-dependent Beta–Thalassemia

Moderator

Moderator:

Dr. Wael Al Kahiry

14:00-14:30

Treatment of myeloma in transplant ineligible patients

Dr. Saud Alhaily

14:30-15:00

Use of TPOs in management of ITP

Dr Enas Damag

15:00-15:25

SCT for SCD

Dr Mohammed Bakkar

15:25-15:45

Q&A

15:45-15:55

SCHEDULE DETAILS Information of Event Schedules

Day 1

Day 2

Business models of cancer care

Current status and future prospective of cancer care in SA

Q&A

Hematology Debate Upfront Brentuximab vedotin in advanced stage HD - Yes

Hematology Debate Upfront Brentuximab vedotin in advanced stage HD - No

Discussion

South region real life experience with adakveo

Prayer and Lunch

Optimizing the use of hu in SCA

Newer therapeutic modalities for SCD

Long-Term Efficacy and Safety of L-Glutamine in Preventing Sickle Cell Disease-Related Acute Complications and Hemolysis in Pediatric and Adult Patients

Q&A

ET & PV: diagnosis and management

ASH guidelines for VTE management

TTP diagnosis and management

Q&A

Closing

Treatment overview of Hemophilia A

Treating AML in unfit or elderly patients

Targeted therapy in CLL patients

Q&A

Moderator

Interpretation of Hb electrophoresis

Beta Thalasemia treatment approach

B-thalassemia: Current and Future Advances

Q&A

Prayer & Lunch

Metabolic Disorders In Hematology Clinics Speaker

Real-life experience with Luspatercept in transfusion-dependent Beta–Thalassemia

Moderator

Treatment of myeloma in transplant ineligible patients

Use of TPOs in management of ITP

SCT for SCD

Q&A

Closing

HURRY UP! Book your Seat